Heo et al. (121) reported that eIF3a is significantly upregulated in HCC tissue compared to normal tissue in mice and patients and combined detection of anti-eIF3a autoantibody and alpha-fetoprotein (AFP) in patient sera improved the accuracy of HCC diagnosis. This evidence concerns the gene AFP and hepatocellular carcinoma.